TradeLink Capital’s bluebird bio BLUE Stock Holding History

TradeLink Capital’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-170	Closed	-$346K	–	13
2019 Q1	$346K	Buy	+170	New	+$299K	1.84%	22

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TradeLink Capital's BLUE Position: Q2 2019 in Review

TradeLink Capital sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 170 shares — an estimated $346K sold.

TradeLink Capital first reported a position in BLUE in Q1 2019 and held it in 1 quarter. The position peaked at $346K in Q1 2019. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

TradeLink Capital reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
TradeLink Capital sold 170 bluebird bio shares in Q2 2019, an estimated $346K.
TradeLink Capital first reported a position in bluebird bio in Q1 2019 and held it in 1 quarter.
TradeLink Capital's bluebird bio position peaked at $346K in Q1 2019.
273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on TradeLink Capital's 13F filing for Q2 2019, filed 31 Jul 2019.